Sulforaphane (Stabilized).

Glucoraphanin only becomes sulforaphane when myrosinase cleaves its thioglucoside bond, and heat processing destroys the plant enzyme. Adding active myrosinase is the single largest determinant of how much sulforaphane is actually formed.

Glucoraphanin is the storage form and sulforaphane is the active isothiocyanate released from it. Pairing preformed sulforaphane with its precursor gives both an immediate and a gut-converted supply.

Sulforaphane acts mainly through Nrf2 and phase II enzyme induction while DIM acts on phase I hydroxylation of oestrogen. They are the isothiocyanate and indole halves of the same vegetable chemistry.

Ascorbate acts as a cofactor for plant myrosinase and shifts hydrolysis of glucoraphanin toward the isothiocyanate rather than the nitrile product. That raises how much usable sulforaphane comes out of a given amount of glucoraphanin.

Sulforaphane is cleared through the mercapturic acid pathway, where glutathione S-transferase attaches it to glutathione. A large cysteine load raises glutathione supply and can pull free sulforaphane into conjugates faster, so the two are not simply additive.

Sulforaphane raises transcription of thioredoxin reductase and glutathione peroxidase, and both are selenoproteins that need selenium at the active site. Without adequate selenium the induced message cannot become functional enzyme.

Both compounds modify cysteine residues on Keap1, which frees Nrf2 to move to the nucleus and switch on phase II genes. They arrive at the same switch through slightly different electrophilic chemistry.

Curcumin is another electrophile that reacts with Keap1 thiols and releases Nrf2. Pairing it with sulforaphane is common formulation practice for a broader push on the same antioxidant response element.

Glucosinolates are the parent thioglucosides that myrosinase converts into isothiocyanates including sulforaphane. A mixed glucosinolate extract widens the pool of precursors beyond glucoraphanin alone.

Sulforaphane is conjugated to glutathione on absorption and then processed down the mercapturic acid pathway, so glutathione is both a downstream product of Nrf2 induction and the vehicle for sulforaphane's own clearance. That gives the pairing two directions at once. Oral glutathione is poorly absorbed intact, which limits how much of a supplemental dose reaches the tissue pool.

Glutathione synthesis needs glutamate, cysteine and glycine, and glycine is added in the second, glutathione synthetase step. Sulforaphane increases expression of both synthesis enzymes through Nrf2, raising the call on all three amino acids. Supplying glycine covers the second step rather than the rate-limiting first one.

Glutamine is the main circulating carrier of the glutamate carbon used in the first step of glutathione synthesis. Nrf2 induction by sulforaphane increases demand for that substrate. This is stoichiometry rather than an observed combination effect.

Transsulfuration converts methionine to cysteine, and cysteine availability is what limits glutathione synthesis in most tissues. A stabilised sulforaphane raises the enzyme capacity for that synthesis without supplying its substrate. The two act at different levels of the same pathway.

A 2026 review of sulforaphane combinations describes overlapping activity with dietary flavonols on the antioxidant response element machinery. Quercetin acts on that machinery indirectly while sulforaphane modifies Keap1 cysteines directly. The evidence base behind the pairing is preclinical.

Resveratrol and sulforaphane are frequently studied together because both touch Nrf2-linked transcription, by different chemistry. The 2026 combinations review covers this class of pairing and frames it as mechanistic. No human combination outcome is established.

Pterostilbene is the dimethylated analogue of resveratrol with greater metabolic stability and similar reported effects on antioxidant response signalling. Combining it with a stabilised isothiocyanate stacks an indirect modulator on a direct Keap1 modifier. Read it as mechanistic rather than clinical.

Catechins from green tea are quinone-forming polyphenols that also induce phase II enzymes, and they appear in the 2026 review of sulforaphane phytochemical combinations. The two are chemically unrelated and reach the same transcriptional endpoint by separate routes. Both are also handled by conjugation pathways that they themselves induce.

Silymarin flavonolignans are reported to increase antioxidant enzyme expression in hepatic tissue, the same tissue where phase II induction by sulforaphane is most studied. The pairing is common in formulation practice on that shared rationale. It is a mechanistic pairing, not a measured combination.

Calcium D-glucarate yields D-glucaro-1,4-lactone, which inhibits beta-glucuronidase and so reduces the deconjugation of glucuronides in the gut. Sulforaphane acts one step earlier by inducing conjugating enzymes. Together they address conjugation and its reversal, which is why the two appear in the same formulas.

Sulfite oxidase is a molybdenum cofactor enzyme, and sulfur-containing compounds including isothiocyanate metabolites end their journey in the sulfur disposal pathways. Molybdenum status therefore sits underneath sulfur handling generally. This is cofactor biochemistry, not a demonstrated interaction with sulforaphane specifically.

Glutathione reductase is a flavoprotein that uses FAD to regenerate reduced glutathione from its oxidised form. Nrf2 induction raises the size of the glutathione pool but the recycling capacity still depends on riboflavin status. The two act on the pool from different sides.

Alpha-tocopherol works as a chain-breaking antioxidant inside membranes, terminating lipid peroxidation directly. Sulforaphane does not scavenge radicals; it increases the enzymes the cell uses to handle them. The two mechanisms are separate and do not substitute for each other.

Stabilised sulforaphane products differ in whether they deliver the free isothiocyanate or the glucosinolate precursor. Where the precursor is delivered, bacterial thioglucosidase activity is what performs the hydrolysis, and certain lactobacilli carry it. For a product delivering free sulforaphane this partner adds nothing to conversion.

MSM is an oxidised organosulfur compound that contributes to the body's sulfur pool, while sulforaphane is a sulfur compound acting as a signalling electrophile. The overlap is elemental rather than mechanistic. The pairing is common in formulation and is thin on direct evidence.